Patent Assignment
Reel/Frame 020764/0547
Assignment of Assignor's Interest
Recorded: 2008-04-07
Pages: 13
Assignors
HOVEYDA, HAMID
Executed: 2008-03-20
FRASER, GRAEME L.
Executed: 2008-03-25
BENAKLI, KAMEL
Executed: 2008-02-29
BEAUCHEMIN, SOPHIE
Executed: 2008-02-13
BRASSARD, MARTIN
Executed: 2008-02-14
DRUTZ, DAVID
Executed: 2008-02-19
MARSAULT, ERIC
Executed: 2008-02-13
OUELLET, LUC
Executed: 2008-02-13
PETERSON, MARK L.
Executed: 2008-02-13
WANG, ZHIGANG
Executed: 2008-02-26
Assignee
TRANZYME PHARMA INC.
SHERBROOKE, QUEBEC, J1H 5N4, CANADA
Covered Property
(1)
Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same
Related Assignments
(11)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 17, 2014
From: TRANZYME PHARMA INC.
To: OCERA THERAPEUTICS, INC.
Reel/Frame 031994/0084 →
Notice of Grant of Security Interest in Intellectual Property
Dec 22, 2017
From: OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044949/0634 →
Security Interest
Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Release of Security Interest
Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED)
Reel/Frame 060389/0839 →
Security Interest
Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
Notice of Grant of Security Interest in Intellectual Property
Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
Release of Security Interests in Patents at Reel 060389/Frame 0913
Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
Reel/Frame 065583/0465 →
Security Interest
Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
Release of Patent Security Interests Recorded at Reel 060434, Frame 0536
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.
Reel/Frame 065601/0347 →
Release of Patent Security Interests Recorded at Reel 044949, Frame 0634
Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.)
Reel/Frame 065610/0460 →
Release of Security Interest
Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072324/0740 →